Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000669656 | SCV000794432 | likely pathogenic | Biotinidase deficiency | 2017-09-26 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000669656 | SCV001810306 | likely pathogenic | Biotinidase deficiency | 2021-07-22 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000669656 | SCV004336326 | pathogenic | Biotinidase deficiency | 2023-10-17 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln106*) in the BTD gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in BTD are known to be pathogenic (PMID: 20083419). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with BTD-related conditions. ClinVar contains an entry for this variant (Variation ID: 554090). For these reasons, this variant has been classified as Pathogenic. |